Literature DB >> 12770797

HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies.

Tamara Kuffner1, William Whitworth, Maya Jairam, Janet McNicholl.   

Abstract

Knowledge of population major histocompatibility complex gene frequencies is important for construction of organ donor pools and for studies of disease association. Human leukocyte antigen DRB1 (HLA-DRB1), HLA-DQB1, and TNFalpha -308 (G-A) promoter genetic typing was performed in 112 healthy, unrelated African Americans (AAs) from the southeastern United States. Allele frequencies were compared with published frequency data from other AA populations. Our AA population had the highest frequency of HLA- DRB1*09 (6.7%) reported in any AA population. The frequency of the TNF alpha -308A polymorphism was also high (14.4%), when compared with published frequencies in AAs. Significant regional differences in the distribution of most HLA-DRB1 and HLA-DQB1 alleles were observed in all AA populations examined. The AA HLA-DRB1 and -DQB1 frequencies also differed from published Caucasian frequencies. This is the first report describing the distribution of TNF alpha promoter alleles in the Southeastern United States. The high DRB1*09 and TNF alpha -308A allele frequencies of our population most resemble the frequencies of these alleles in certain West African populations. These varying major histocompatibility complex gene frequencies may reflect different regional population structures among AAs in the United States, which may be due to differences in ancestral origins, migration, and racial admixture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770797     DOI: 10.1016/s0198-8859(03)00056-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Practical Consideration of Genotype Imputation: Sample Size, Window Size, Reference Choice, and Untyped Rate.

Authors:  Boshao Zhang; Degui Zhi; Kui Zhang; Guimin Gao; Nita N Limdi; Nianjun Liu
Journal:  Stat Interface       Date:  2011       Impact factor: 0.582

Review 2.  Gene-environment interactions in sarcoidosis: challenge and opportunity.

Authors:  Daniel A Culver; Lee S Newman; Mani S Kavuru
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

3.  Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.

Authors:  Nita A Limdi; Donna K Arnett; Joyce A Goldstein; T Mark Beasley; Gerald McGwin; Brian K Adler; Ronald T Acton
Journal:  Pharmacogenomics       Date:  2008-05       Impact factor: 2.533

4.  Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy.

Authors:  N A Limdi; T M Beasley; D B Allison; C A Rivers; R T Acton
Journal:  Blood Cells Mol Dis       Date:  2006-08-02       Impact factor: 3.039

5.  VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.

Authors:  Nita A Limdi; T Mark Beasley; Michael R Crowley; Joyce A Goldstein; Mark J Rieder; David A Flockhart; Donna K Arnett; Ronald T Acton; Nianjun Liu
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

6.  Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.

Authors:  Alexander Dew; Demetria Collins; Andrew Artz; Elizabeth Rich; Wendy Stock; Kate Swanson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2008-08       Impact factor: 5.742

7.  Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.

Authors:  Na Limdi; Ja Goldstein; Ja Blaisdell; Tm Beasley; Ca Rivers; Rt Acton
Journal:  Per Med       Date:  2007-05-01       Impact factor: 2.512

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.